biota is going to get smashed, page-8

Trouble is with these boards is that they are not traders. They see a general weakness in the price and commence a buy back... it's not a very precise process.

I still think they should conserve all cash... they will have trouble raising cash in the immediate future and why do a share buy back when you can buy other companies at "cheap" prices?

Just hope they don't do something silly and start another buy back. For once they have something like 20c per share cash backing rather than 1 or 2c like other biotechs. They should keep that position as long as possible.

Quarterly sales coming, US stock market sinking, small cap liquidity drying up... all points to weakness for BTA. 40c-60c trading range is here and I don't see us breaking out any time soon.